Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Ellen E. Baxter
Introduction
Ellen E. Baxter is a notable inventor based in Glenside, Pennsylvania. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Alzheimer's disease. Her work has led to the creation of a patent that showcases her innovative spirit and dedication to improving healthcare.
Latest Patents
Ellen E. Baxter holds a patent for "2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE)." This invention is directed towards novel compounds that serve as inhibitors of β-secretase, also known as β-site cleaving enzyme and BACE. The pharmaceutical compositions containing these derivatives are aimed at treating Alzheimer's disease and related disorders. This patent highlights her commitment to addressing critical health challenges.
Career Highlights
Ellen E. Baxter has been associated with Janssen Pharmaceutica NV, where she has contributed her expertise in pharmaceutical research and development. Her work has been instrumental in advancing the understanding of Alzheimer's disease and the potential therapeutic options available for patients.
Collaborations
Ellen has collaborated with esteemed colleagues such as Christopher John Creighton and Yifang Huang. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Ellen E. Baxter's contributions to the field of pharmaceuticals, particularly in the development of Alzheimer's treatments, underscore her role as a leading inventor. Her patent and collaborations reflect her dedication to improving patient outcomes through innovative solutions.